Long-term Effectiveness and Safety in Hepatitis-co-infected Patients.
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2011
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 10 Jun 2017 Biomarkers information updated
- 27 Jun 2011 Actual end date change from Jun 2010 to Nov 2010 as reported by ClinicalTrials.gov.
- 27 Jun 2011 Actual initiation date change from Jun 2004 to May 2001 as reported by ClinicalTrials.gov.